In a systemic lupus erythematosus (SLE) model, artesunate was found to effectively reduce Tfh levels in the spleen of SLE mice, increase Tfr levels, maintain the Tfr/Tfh ratio, reduce SLE severity, and prolong survival (55). Here, TFRC is linked to systemic lupus erythematosus.